Access in India

Regulatory framework

India's CDSCO permits import of unapproved drugs under Rule 36 for personal use by patients with a prescription from a registered medical practitioner. Named Patient import is common for rare-disease indications.

Case active and ready to skip the regulatory walkthrough? Ask about a medicine or WhatsApp us.

Typical timeline

We give you a written timeline estimate for your case before you commit. Timing depends on the specific drug, the clinical justification, and destination-regulator review pace.

What a typical process looks like

1. Patient or physician submits a request with drug name and indication.
2. We verify clinical appropriateness and document eligibility.
3. Treating physician issues prescription and clinical justification.
4. Country-specific regulatory documentation is prepared and submitted.
5. Patient pre-pays; we source via DSCSA-compliant US wholesaler.
6. Drug ships cold-chain to destination physician or hospital pharmacy.
7. Physician receives, confirms storage, and begins treatment.

Popular drug requests from India